Publications of Institute of Radiopharmaceutical Cancer Research - Year 2014
9 Publications2014
Organotypical vascular model for characterization of radioprotective compounds: Studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors
Ullm, S.; Laube, M.; Bechmann, N.; Knieß, T.; Pietzsch, J.
-
Clinical Hemorheology and Microcirculation 58(2014), 281-295
DOI: 10.3233/CH-141902
2,3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development
Laube, M.; Tondera, C.; Sharma, S. K.; Bechmann, N.; Pietzsch, F.-J.; et al. (10 authors)
-
RSC Advances 4(2014), 38726-38742
DOI: 10.1039/c4ra05650g
In Vivo Fluorescence Imaging and Urinary Monoamines as Surrogate Biomarkers of Disease Progression in a Mouse Model of Pheochromocytoma
Ullrich, M.; Bergmann, R.; Peitzsch, M.; Cartellieri, M.; Quin, N.; et al. (12 authors)
-
Endocrinology 155(2014), 4149-4156
DOI: 10.1210/en.2014-1431
ISSN: 0013-7227
Biocompatibility and inflammatory response in vitro and in vivo to gelatin-based biomaterials with tailorable elastic properties
Ullm, S.; Krüger, A.; Tondera, C.; Gebauer, T. P.; Neffe, A. T.; et al. (8 authors)
-
Biomaterials 35(2014), 9755-9766
DOI: 10.1016/j.biomaterials.2014.08.023
ISSN: 0142-9612
Bispidine dioxotetraaza macrocycles: a new class of bispidines for 64Cu PET imaging
Comba, P.; Kubeil, M.; Pietzsch, J.; Rudolf, H.; Stephan, H.; et al. (6 authors)
-
Inorganic Chemistry 53(2014), 6698-6707
DOI: 10.1021/ic500476u
Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2
Pretze, M.; Mosch, B.; Bergmann, R.; Steinbach, J.; Pietzsch, J.; et al. (6 authors)
-
Journal of Labelled Compounds and Radiopharmaceuticals 57(2014), 660-665
DOI: 10.1002/jlcr.3237
Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages
Haase-Kohn, C.; Wolf, S.; Herwig, N.; Mosch, B.; Pietzsch, J.
-
Biochemical and Biophysical Research Communications 446(2014), 143-148
DOI: 10.1016/j.bbrc.2014.02.126
Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential
Koi, L.; Bergmann, R.; Brüchner, K.; Pietzsch, J.; Pietzsch, H.-J.; et al. (9 authors)
-
Radiotherapy and Oncology 110(2014), 362-369
DOI: 10.1016/j.radonc.2013.12.001
Radiolabeled cetuximab conjugates for EGFR targeted cancer diagnostics and therapy
Sihver, W.; Pietzsch, J.; Krause, M.; Baumann, M.; Steinbach, J.; et al. (6 authors)
-
Pharmaceuticals 7(2014)3, 311-338
DOI: 10.3390/ph7030311
Years: 2018 2017 2016 2015 2014 2013 2012 2011 2010
